WA-ITRON
4.10.2021 14:47:08 CEST | Business Wire | Press release
Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, released its 2021 Resourcefulness Insight Report detailing why modernizing energy infrastructure is the path to achieving a resilient and reliable grid that successfully mitigates the impacts of climate disruption, minimizes interruptions from natural disasters, integrates renewables and prepares for the increased adoption of electric vehicles (EVs). Preparing for the Unexpected and the Inevitable: An Itron Resourcefulness Report summarizes key findings from surveys of 500 utility executives and 500 informed consumers from across five countries – United States, Australia, France, Germany and Indonesia – on the key challenges, barriers and concerns facing utilities in the next five years.
Launched today at Itron Inspire 2021, the company’s premier customer-focused event, the report dives deep into the differing opinions of consumers and utility executives related to resilience planning for an innovative, reliable grid. Across the surveyed countries, integrating renewables and modernizing aging grid infrastructure are the top two biggest challenges. The findings indicate that in the next five years utility execs surveyed see EV demands becoming the biggest challenge for the grid. Additional key findings in the report show:
- Consumers agree with the top priorities of integrating renewables and upgrading infrastructures. However, they are more concerned about natural disasters (20%) than EVs (16%).
- Utility executives are extremely/very concerned about the grid and the impact of disasters (88%), demand from EVs (85%), integrating renewables (86%) and complying with environmental mandates (90%).
- Consumers are less concerned than utility executives about the impact of disasters and EVs on the grid, however they are also less confident in how prepared utilities are to manage these situations with 84% of utilities stating they are ready vs. 47% of consumers.
“In looking at these results, there is agreement on the need for grid modernization, but utility executives and consumers have different concerns and priorities. We see that utilities are looking to the future to plan and prepare for what is coming, while consumers indicated more immediate concerns,” said Marina Donovan, vice president of global marketing and public affairs. “Consumers remain concerned about how climate disruption – and the resulting rise in natural disasters – are impacting their lives, yet they are less aware or even unaware of the impact of EVs and renewables on the grid.”
Across all five countries, the biggest challenges to the reliability and resiliency of the grid are upgrading aging infrastructure, integrating renewables and complying with carbon mandates, but these priorities change as executives look to the future:
|
Today |
In Five Years |
US |
Upgrading grid |
Upgrading grid |
Australia |
Upgrading grid |
Meeting EV demand & upgrading grid |
France |
Integrating renewables |
Meeting EV demand |
Germany |
Complying with carbon mandates |
Meeting EV demand |
Indonesia |
Integrating renewables |
Integrating renewables |
According to the survey, the COVID-19 pandemic has delayed technology investments across all the countries. Yet, the technology is critical to create a more resilient infrastructure. The report notes that advanced metering infrastructure and distribution automation are high priorities for EVs, distributed energy resources (DER) deployments, and disaster response. And sensors are the highest priority technology for grid resiliency in the face of disasters.
“In America, the U.S. Senate passed a $1.2 trillion bipartisan infrastructure bill, which is currently being debated in the House of Representatives, that will be critical to driving grid modernization. Replacing aging electrical infrastructure is paramount to making the grid more resilient and reliable in the face of extreme weather conditions and climate disruption. This federal investment is needed to protect and prepare for disasters as well as sustainable growth,” added Donovan.
To download a full copy of the Itron Resourcefulness Insight Report, visit www.itron.com/resourceful . To listen to key sessions and keynotes at the virtual Itron Inspire Event, Oct. 4-6, please visit www.itron.com/inspire .
About Itron
Itron enables utilities and cities to safely, securely and reliably deliver critical infrastructure solutions to communities in more than 100 countries. Our portfolio of smart networks, software, services, meters and sensors helps our customers better manage electricity, gas and water resources for the people they serve. By working with our customers to ensure their success, we help improve the quality of life, ensure the safety and promote the well-being of millions of people around the globe. Itron is dedicated to creating a more resourceful world. Join us: www.itron.com .
Itron® is a registered trademark of Itron, Inc. All third-party trademarks are property of their respective owners, and any usage herein does not suggest or imply any relationship between Itron and the third party unless expressly stated.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211004005176/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
